Publications by authors named "Stephen D Ryder"

Claim this Profile
S
Screening for Alcohol Use Disorder Among Hospitalised Patients: Learning from a Retrospective Cohort Study in Secondary Care.
Mohsan Subhani, Dipaka Rani Nath, Usman Talat, Aqsa Imtiaz, Amardeep Khanna, Stephen D Ryder

J Clin Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIV.
Leanne McCabe, James E Burns, Arash Latifoltojar, Frank A Post, Julie Fox, Stephen D Ryder

AIDS· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Top ten research priorities for alcohol use disorder and alcohol-related liver disease: results of a multistakeholder research priority setting partnership.
Mohsan Subhani, Ashwin Dhanda, Adina Olaru, Louise Dunford, Nahid Ahmad, Stephen D Ryder

Lancet Gastroenterol Hepatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In severe alcohol-related hepatitis, acute kidney injury is prevalent, associated with mortality independent of liver disease severity, and can be predicted using IL-8 and micro-RNAs.
Luke D Tyson, Stephen Atkinson, Robert W Hunter, Michael Allison, Andrew Austin, Stephen D Ryder

Aliment Pharmacol Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application and Extension of the Alcohol Recovery Narratives Conceptual Framework.
Mohsan Subhani, Usman Talat, Holly Knight, Joanne R Morling, Katy A Jones, Stephen D Ryder

Qual Health Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient Elastography and Video Recovery Narrative Access to Support Recovery From Alcohol Misuse: Development of a Novel Intervention for Use in Community Alcohol Treatment Services.
Stefan Rennick-Egglestone, Mohsan Subhani, Holly Knight, Katy A Jones, Clare Hutton, Stephen D Ryder

JMIR Form Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
Homie A Razavi, Maria Buti, Norah A Terrault, Stefan Zeuzem, Cihan Yurdaydin, Stephen D Ryder

J Hepatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Gideon M Hirschfield, Mitchell L Shiffman, Aliya Gulamhusein, Kris V Kowdley, John M Vierling, Stephen D Ryder

Hepatology· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.
Victoria Hamill, Stanley Wong, Jennifer Benselin, Mel Krajden, Peter C Hayes, Stephen D Ryder

BMJ· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does knowledge of liver fibrosis affect high-risk drinking behaviour (KLIFAD): an open-label pragmatic feasibility randomised controlled trial.
Mohsan Subhani, Doyo G Enki, Holly Knight, Katy A Jones, Kirsty Sprange, Stephen D Ryder

EClinicalMedicine· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring changing attitudes to non-invasive liver fibrosis tests in secondary care pathways: comparison of two national surveys.
Kushala W M Abeysekera, Ankur Srivastava, Ian Rowe, Helen Jarvis, Stephen D Ryder

Frontline Gastroenterol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis.
Ira M Jacobson, Stefan Bourgeois, Phillipe Mathurin, Paul Thuluvath, Stephen D Ryder

J Viral Hepat· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis.
Laura Martinez-Gili, Alexandros Pechlivanis, Julie A K McDonald, Sofina Begum, Jonathan Badrock, Stephen D Ryder

Gut Microbes· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK.
Victoria Hamill, Will Gelson, Douglas MacDonald, Paul Richardson, Stephen D Ryder

Liver Int· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of immune responses in primary biliary cholangitis: a transcriptomic analysis of peripheral immune cells.
Victoria Mulcahy, Evaggelia Liaskou, Jose-Ezequiel Martin, Prasanti Kotagiri, Jonathan Badrock, Stephen D Ryder

Hepatol Commun· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trial.
Louise China, Thais Tittanegro, Dominic Crocombe, Ewan Forrest, Yiannis Kallis, Stephen D Ryder

EClinicalMedicine· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of National Survey of the Practice of Hepatocellular Carcinoma Surveillance.
Robert A Scott, Timothy J S Cross, Christopher Clarke, Shahid A Khan, Stephen D Ryder

J Hepatocell Carcinoma· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Role of Antibiotics in Patients Admitted to Hospital With Decompensated Cirrhosis: Lessons From the ATTIRE Trial.
Rishen Kutmutia, Thais Tittanegro, Louise China, Ewan Forrest, Yiannis Kallis, Stephen D Ryder

Am J Gastroenterol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: Data from the ATTIRE trial.
Thais Tittanegro, Louise China, Ewan Forrest, Yiannis Kallis, Stephen D Ryder

EClinicalMedicine· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus.
Aminata Sy, Leanne McCabe, Emma Hudson, Azim M Ansari, Vincent Pedergnana, Stephen D Ryder

PLoS One· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II).
Richard J Aspinall, Mark Hudson, Stephen D Ryder, Paul Richardson, Elizabeth Farrington

Frontline Gastroenterol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alcohol-related liver disease mortality and missed opportunities in secondary care: A United Kingdom retrospective observational study.
Mohsan Subhani, Rebecca Elleray, Jane Bethea, Joanne R Morling, Stephen D Ryder

Drug Alcohol Rev· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASEPTIC: primary antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis-study protocol for an interventional randomised controlled trial.
Dominic Crocombe, Norin Ahmed, Indran Balakrishnan, Ekaterina Bordea, Marisa Chau, Stephen D Ryder

Trials· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and prevalence of venous thromboembolism in chronic liver disease: A systematic review and meta-analysis.
Mohsan Subhani, Abhishek Sheth, Jamal Ahmed, Pramudi Wijayasiri, Syed A Gardezi, Stephen D Ryder

Thromb Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study.
David E J Jones, Aaron Wetten, Ben Barron-Millar, Laura Ogle, George Mells, Stephen D Ryder

EBioMedicine· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis